China Pharma Holdings Statistics
Total Valuation
CPHI has a market cap or net worth of $3.64 million. The enterprise value is $6.76 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CPHI has 19.25 million shares outstanding. The number of shares has increased by 616.92% in one year.
| Current Share Class | 19.25M |
| Shares Outstanding | 19.25M |
| Shares Change (YoY) | +616.92% |
| Shares Change (QoQ) | +7.33% |
| Owned by Insiders (%) | 47.86% |
| Owned by Institutions (%) | 0.21% |
| Float | 10.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| Forward PS | n/a |
| PB Ratio | 0.49 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.61.
| Current Ratio | 0.79 |
| Quick Ratio | 0.23 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.21 |
Financial Efficiency
Return on equity (ROE) is -75.07% and return on invested capital (ROIC) is -25.96%.
| Return on Equity (ROE) | -75.07% |
| Return on Assets (ROA) | -19.85% |
| Return on Capital (ROIC) | -25.96% |
| Revenue Per Employee | $24,003 |
| Profits Per Employee | -$20,537 |
| Employee Count | 231 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.12% in the last 52 weeks. The beta is 0.66, so CPHI's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -68.12% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 46.94 |
| Average Volume (20 Days) | 399,375 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CPHI had revenue of $5.54 million and -$4.74 million in losses. Loss per share was -$0.35.
| Revenue | 5.54M |
| Gross Profit | -1.90M |
| Operating Income | -4.58M |
| Pretax Income | -3.56M |
| Net Income | -4.74M |
| EBITDA | -1.71M |
| EBIT | -4.58M |
| Loss Per Share | -$0.35 |
Full Income StatementBalance Sheet
The company has $718,691 in cash and $4.01 million in debt, giving a net cash position of -$3.29 million or -$0.17 per share.
| Cash & Cash Equivalents | 718,691 |
| Total Debt | 4.01M |
| Net Cash | -3.29M |
| Net Cash Per Share | -$0.17 |
| Equity (Book Value) | 6.53M |
| Book Value Per Share | 0.37 |
| Working Capital | -1.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$727,159 and capital expenditures -$23,393, giving a free cash flow of -$750,552.
| Operating Cash Flow | -727,159 |
| Capital Expenditures | -23,393 |
| Free Cash Flow | -750,552 |
| FCF Per Share | -$0.04 |
Full Cash Flow StatementMargins
Gross margin is -34.34%, with operating and profit margins of -82.55% and -85.56%.
| Gross Margin | -34.34% |
| Operating Margin | -82.55% |
| Pretax Margin | -85.56% |
| Profit Margin | -85.56% |
| EBITDA Margin | -30.87% |
| EBIT Margin | -82.55% |
| FCF Margin | n/a |